NAP1L1 and hepatocellular carcinoma: Among the 4 candidate proteins, UBE2O has been proved to bind to NAP1L1 [29] and promote EMT in head and neck squamous cell carcinoma [30] and breast cancer [31], but the relationship between UBE2O and NAP1L1 and EMT in HCC has not been studied.